EUCTR2007-004021-19-FI进行中（未招募）1 期
OPHO ALL-2008 Pilot Study on consolidation therapy for children and young adults with acute lymphoblastic leukaemia
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •B-lineage ALL with a white blood cell count of < 100 x 10E9/l and age at diagnosis 1.0-17.9 yrs, no t(9;22), no hypodiploidy, no 11q23(MLL)-aberrations, no t(1;19), no TPMT deficiency, no known intolerance to MD-MTX and/or oral 6MP and a written consent obtained for participation.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •If not one of the above is met
研究者
相似试验
进行中（未招募）
不适用
OPHO ALL-2008 PILOT STUDY ON CONSOLIDATION THERAPY FOR CHILDREN AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA - ALL2008pEUCTR2007-004021-19-SERigshospitalet75
进行中（未招募）
1 期
OPHO ALL-2008 PILOT STUDY ON CONSOLIDATION THERAPY FOR CHILDREN AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA - ALL2008pAcute lymphoblastic leukemia in children 1.0-18 years of ageMedDRA version: 9.1Level: LLTClassification code 10066109Term: Precursor B-lymphoblastic leukemia acuteEUCTR2007-004021-19-DKRigshospitalet75
进行中（未招募）
不适用
A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.SQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395EUCTR2005-001132-72-ITISTITUTO EUROPEO DI ONCOLOGIA42
招募中
2 期
Induction of remission and consolidation therapy using ATRA and ATO for acute promyelocytic leukemia - JSCT APL2021Acute promyelocytic leukemiaJPRN-jRCTs071210035Takase Ken90
尚未招募
1 期
A study in blood cancer patients to check the effect of two oral drugs in maintaining the status of the patient disease free. The medicines that will be given are azacytidine and pomalidomide.CTRI/2023/09/057552Tata Memorial Centre